Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma

被引：0
|
作者：
Brian A. Boone
Nathan Bahary
Amer H Zureikat
A. James Moser
Daniel P Normolle
Wen-Chi Wu
Aatur D. Singhi
Phillip Bao
David L Bartlett
Lance A Liotta
Virginia Espina
Patricia Loughran
Michael T. Lotze
Herbert J. Zeh
机构：
[1] University of Pittsburgh,Department of Surgery
[2] University of Pittsburgh,Department of Medicine
[3] University of Pittsburgh,Department of Pathology
[4] University of Pittsburgh,Department of Biostatistics
[5] George Mason University,Center for Applied Proteomics and Molecular Medicine
[6] Harvard Medical School,Institute for Hepatobiliary and Pancreatic Surgery, Beth Israel Deaconess Medical Center
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Gemcitabine; Pancreatic Ductal Adenocarcinoma; Stereotactic Body Radiotherapy; Autophagy Inhibition; Pancreatic Carcinogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4402 / 4410
页数：8
相关论文
共 50 条
  • [31] Adherence to Pre-operative Exercise and the Response to Prehabilitation in Oesophageal Cancer Patients
    Laura J. Halliday
    Emre Doganay
    Venetia Wynter-Blyth
    Hayley Osborn
    John Buckley
    Krishna Moorthy
    Journal of Gastrointestinal Surgery, 2021, 25 : 890 - 899
  • [32] Genomic and transcriptomic characterization of pre-operative chemotherapy response in patients with osteosarcoma
    Yang, Yongkun
    Huang, Zhen
    Yuan, Mingming
    Rui, Jinqiu
    Chen, Rongrong
    Jin, Tao
    Sun, Yang
    Deng, Zhiping
    Shan, Huachao
    Niu, Xiaohui
    Liu, Weifeng
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [33] RESECTABLE PANCREATIC ADENOCARCINOMA: IS THE ENHANCEMENT PATTERN AT CONTRAST-ENHANCED ULTRASONOGRAPHY A PRE-OPERATIVE PROGNOSTIC FACTOR?
    D'Onofrio, M.
    Zamboni, G. A.
    Malago, R.
    Mantovani, W.
    Principe, F.
    Gallotti, A.
    Faccioli, N.
    Falconi, M.
    Capelli, P.
    Mucelli, R. Pozzi
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2009, 35 (12): : 1929 - 1937
  • [34] Genomic and transcriptomic characterization of pre-operative chemotherapy response in patients with osteosarcoma
    Yongkun Yang
    Zhen Huang
    Mingming Yuan
    Jinqiu Rui
    Rongrong Chen
    Tao Jin
    Yang Sun
    Zhiping Deng
    Huachao Shan
    Xiaohui Niu
    Weifeng Liu
    Scientific Reports, 13
  • [35] Pre-operative serum levels of CA72-4 in patients with gastric adenocarcinoma
    Ikeguchi, M
    Katano, K
    Saitou, H
    Tsujitani, S
    Maeta, M
    Kaibara, N
    HEPATO-GASTROENTEROLOGY, 1997, 44 (15) : 866 - 871
  • [36] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck
    Schmitz, S.
    Hamoir, M.
    Reychler, H.
    Magremanne, M.
    Weynand, B.
    Lhommel, R.
    Hanin, F. -X.
    Duprez, T.
    Michoux, N.
    Rommel, D.
    Lonneux, M.
    Cappoen, N.
    Gillain, A.
    Machiels, J. -P.
    ANNALS OF ONCOLOGY, 2013, 24 (09) : 2261 - 2266
  • [37] The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation
    Charalampakis, Nikolaos
    Gonzalez, Graciela M. Nogueras
    Elimova, Elena
    Wadhwa, Roopma
    Shiozaki, Hironori
    Shimodaira, Yusuke
    Blum, Mariela A.
    Rogers, Jane E.
    Harada, Kazuto
    Matamoros, Aurelio, Jr.
    Sagebiel, Tara
    Das, Prajnan
    Minsky, Bruce D.
    Lee, Jeffrey H.
    Weston, Brian
    Bhutani, Manoop S.
    Estrella, Jeannelyn S.
    Badgwell, Brian D.
    Ajani, Jaffer A.
    ONCOLOGY, 2016, 90 (05) : 239 - 247
  • [38] Efficacy and safety of gemcitabine in combination with TH-302 compared with gemcitabine in combination with placebo in previously untreated patients with metastatic or locally advanced unresectable pancreatic adenocarcinoma: The MAESTRO trial
    Van Cutsem, Eric
    Fram, Robert J.
    Schlichting, Michael
    Ryan, David P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] The combination of a chemotherapy doublet (gemcitabine plus capecitabine) with a biologic doublet (bevacizumab plus erlotinib) in patients with advanced pancreatic adenocarcinoma : The TARGET study.
    Watkins, D. J.
    Starling, N.
    Chau, I.
    Thomas, J.
    Webb, J.
    Oates, J. R.
    Brown, G.
    Thomas, K.
    Cunningham, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
    Mahalingam, Devalingam
    Goel, Sanjay
    Aparo, Santiago
    Arora, Sukeshi Patel
    Noronha, Nicole
    Hue Tran
    Chakrabarty, Romit
    Selvaggi, Giovanni
    Gutierrez, Andres
    Coffey, Matthew
    Nawrocki, Steffan T.
    Nuovo, Gerard
    Mita, Monica M.
    CANCERS, 2018, 10 (06)
12345